Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Sporn

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Nature Clinical Practice. Oncology|July 11, 2006
Dichotomies in cancer research: some suggestions for a new synthesisMichael B Sporn
Nature Reviews. Cancer|July 3, 2002
Chemoprevention: an essential approach to controlling cancerMichael B Sporn, Nanjoo Suh
Nature Reviews. Cancer|January 16, 2007
The tumour microenvironment as a target for chemopreventionAdriana Albini, Michael B Sporn
Pharmacological Reviews|September 12, 2012
Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic diseaseKaren T Liby, Michael B Sporn
Nature Reviews. Cancer|July 20, 2012
NRF2 and cancer: the good, the bad and the importance of contextMichael B Sporn, Karen T Liby
Nature Clinical Practice. Oncology|October 6, 2005
Cancer chemoprevention: scientific promise, clinical uncertaintyMichael B Sporn, Karen T Liby
Current Topics in Medicinal Chemistry|June 21, 2016
Rexinoids for prevention and treatment of cancer: opportunities and challengesKaren T Liby, Michael B Sporn
Cancer Prevention Research (Philadelphia, Pa.)|March 14, 2013
Is lycopene an effective agent for preventing prostate cancer?Michael B Sporn, Karen T Liby
Nature Clinical Practice. Oncology|August 30, 2008
Concomitant DFMO and sulindac chemoprevention of colorectal adenomas: a major clinical advanceMichael B Sporn, Waun Ki Hong
Nature Reviews. Cancer|April 21, 2007
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancerKaren T Liby, Mark M Yore, Michael B Sporn
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Nature Clinical Practice. Oncology|July 11, 2006
Dichotomies in cancer research: some suggestions for a new synthesisMichael B Sporn
Nature Reviews. Cancer|July 3, 2002
Chemoprevention: an essential approach to controlling cancerMichael B Sporn, Nanjoo Suh
Nature Reviews. Cancer|January 16, 2007
The tumour microenvironment as a target for chemopreventionAdriana Albini, Michael B Sporn
Pharmacological Reviews|September 12, 2012
Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic diseaseKaren T Liby, Michael B Sporn
Nature Reviews. Cancer|July 20, 2012
NRF2 and cancer: the good, the bad and the importance of contextMichael B Sporn, Karen T Liby
Nature Clinical Practice. Oncology|October 6, 2005
Cancer chemoprevention: scientific promise, clinical uncertaintyMichael B Sporn, Karen T Liby
Current Topics in Medicinal Chemistry|June 21, 2016
Rexinoids for prevention and treatment of cancer: opportunities and challengesKaren T Liby, Michael B Sporn
Cancer Prevention Research (Philadelphia, Pa.)|March 14, 2013
Is lycopene an effective agent for preventing prostate cancer?Michael B Sporn, Karen T Liby
Nature Clinical Practice. Oncology|August 30, 2008
Concomitant DFMO and sulindac chemoprevention of colorectal adenomas: a major clinical advanceMichael B Sporn, Waun Ki Hong
Nature Reviews. Cancer|April 21, 2007
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancerKaren T Liby, Mark M Yore, Michael B Sporn
Pageof 12